Company Snapshot: PDLI  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Protein Design Labs Announces Webcast of Third Quarter Financial Results Conference Call

    FREMONT, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Protein Design Labs,
Inc. (PDL) (Nasdaq: PDLI) today announced that its financial results for the
third quarter ended September 30, 2004 will be released following the close of
the U.S. financial markets on Monday, November 1, 2004.  PDL will hold a
conference call to discuss these results, the status of its clinical
development programs, and its forward-looking information and guidance with
respect to remaining 2004 results at 4:30 p.m. Eastern time on November 1,
2004.  The call will be hosted by Mr. Mark McDade, Chief Executive Officer,
Mr. Glen Y. Sato, Senior Vice President and Chief Financial Officer, and
Dr. Steven Benner, Senior Vice President and Chief Medical Officer.
    The live webcast will be available through the PDL website:  http://www.pdl.com.
Please connect to this website at least 15 minutes prior to the live webcast
to allow time for any software download that may be needed to hear the
webcast.  A replay will be available at http://www.pdl.com starting approximately one
hour after completion of the webcast.
    An audio replay will also be available by telephone from approximately
6:30 p.m. Eastern time on November 1, 2004 through 6:30 p.m. Eastern time on
November 4, 2004.  To access the replay, dial 800-633-8284 from inside the
United States and 402-977-9140 from outside the United States; enter
conference ID number 21212418.

    Protein Design Labs is a leader in the development of humanized antibodies
to prevent or treat various disease conditions.  PDL currently has antibodies
under development for autoimmune and inflammatory conditions, asthma and
cancer.  PDL holds fundamental patents for its antibody humanization
technology.  Further information on PDL is available at http://www.pdl.com.

    NOTE:  Protein Design Labs and the PDL logo are registered U.S. trademarks
of Protein Design Labs, Inc.


SOURCE Protein Design Labs, Inc.




Back to Topback to top

Related links:
  • http://www.pdl.com
    CONTACT:
    James R. Goff, Senior Director, Corporate
    Communications of Protein Design Labs, Inc., +1-510-574-1421, or
    jgoff@pdl.com